Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

OSPAMOX TABLET 500 mg - HSA Drug Approval Details

Approvals/HSA/OSPAMOX TABLET 500 mg

Approved

THERAPEUTIC

OSPAMOX TABLET 500 mg

SANDOZ GMBH🇸🇬 Health Sciences Authority

Approval Date: Sep 22, 1989
Approval ID: 69b1f3edc05a081a
Company: SANDOZ GMBH
Type: Therapeutic

Approval Details

Approval Id: 69b1f3edc05a081a
Drug Name: OSPAMOX TABLET 500 mg
Product Name: OSPAMOX TABLET 500 mg
Approval Number: SIN03690P
Approval Date: 1989-09-22
Registrant: NOVARTIS (SINGAPORE) PTE LTD
Licence Holder: SANDOZ SINGAPORE PTE. LTD.
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: TABLET, FILM COATED
Route Of Administration: ORAL
Atc Code: J01CA04
Atc Item Name: amoxicillin
Pharma Manufacturer Name: SANDOZ SINGAPORE PTE. LTD.
Company Detail Path: /organization/sandoz-singapore-pte-ltd

Active Ingredients

AMOXYCILLIN TRIHYDRATE 574mg eqv. AMOXYCILLIN

500mg

AMOXYCILLIN TRIHYDRATE 574mg eqv. AMOXYCILLIN

500mg

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Sep 22, 1989

Approval ID

69b1f3edc05a081a

Type

Therapeutic

Back to HSA Approvals